Max India Limited (MAXIND) Earnings Call Transcripts

15 earnings calls from February 2023 to August 12, 2026

IN Health Care Health Care Providers and Services

Max India Limited's Latest Earnings Call - Q4 FY2026

Max India Limited reported its Q4 FY '26 earnings, showing significant improvements in revenue and reduced losses, which could positively impact the stock. The company achieved a consolidated revenue of INR 213.4 crores for FY '26, a 30% increase from INR 164 crores in FY '25. The EBITDA loss improved to INR 83 crores from INR 99 crores in the previous year. Quarterly revenue for Q4 was INR 72 crores, reflecting a 45% Q-on-Q growth and a 58% YoY growth. Management did not provide specific guidance changes but indicated a focus on profitability and expansion.

Reported metrics

MetricValueContext
Consolidated Revenue INR 213.4 crores (beat) vs INR 164 crores in FY '25, +30% YoY
EBITDA Loss INR 83 crores (beat) vs INR 99 crores in FY '25, improvement
Quarterly Revenue (Q4) INR 72 crores (beat) vs INR 49.8 crores in Q3 FY '26, +45% Q-on-Q
Consolidated Loss INR 6.8 crores (beat) vs INR 27.8 crores in Q3 FY '26, significant reduction
AGEasy Revenue INR 77 crores (beat) 100% YoY growth
Bed Capacity 485 beds (neutral) across NCR, Bengaluru, Chennai

Guidance from management

Management did not provide specific forward guidance but emphasized a focus on achieving profitability and expanding their residential and care services. They expect further improvement in financial performance in FY '27.

What management said

Yes. So Harsh, on launch of Phase 2 of E361 is around the corner. You'll find in the next few days, we will make that announcement because, as I said, 140 of the 180 have been sold, and we don't have inventory left for a certain type. There is demand still. So that you'll find very soon. Yes, the collections are lumpy. You're absolutely right. And therefore, most of the collection we have done now are the booking fee...
— Rajit Mehta, Q4 FY2026 earnings call
And this booking fee will continue -- Harsh, this is Ajay. So this booking will continue till the time we do the sales. To our understanding, it will be 20% collection, which will come as a time-bound manner. So a booking fee of INR 25 lakhs, then 10% on application and then one more 10%. Then the collection based on construction takes approximately 3 quarters, and then it becomes very periodic. So it will be lumpy i...
— Ajay Agrawal, Q4 FY2026 earnings call

What analysts pressed on

Analysts questioned the timeline for launching Phase 2 of Estate361 and the impact of geopolitical tensions on raw material costs for AGEasy. Concerns were also raised about the high staff costs relative to revenue and the company's conservative growth approach over the past decade.

Main topics on the call

Read the full Max India Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Max India Limited

Max India Limited (MAXIND) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 15 calls on record spanning February 2, 2023 to August 12, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 15 Max India Limited earnings call transcripts on record, spanning February 2, 2023 to August 12, 2026. Based on this history, Max India Limited reports quarterly. The most recent call on file is dated August 12, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
MAXIND
Country
IN
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
15
First call
February 2, 2023
Most recent
August 12, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2027 Aug 12, 2026 Read transcript
Q1 FY2027 Aug 12, 2026 Read transcript
Q4 FY2026 May 29, 2026 Read transcript
Q3 FY2026 Feb 10, 2026 Read transcript
Q2 FY2026 Nov 14, 2025 Read transcript
Q2 FY2026 Aug 6, 2025 Read transcript
Q3 FY2025 Feb 7, 2025 Read transcript
Q2 FY2025 Oct 24, 2024 Read transcript
Q1 FY2025 Aug 14, 2024 Read transcript
Q4 FY2024 May 24, 2024 Read transcript
Q3 FY2024 Feb 8, 2024 Read transcript
Q2 FY2024 Oct 27, 2023 Read transcript
Q1 FY2024 Aug 11, 2023 Read transcript
Q4 FY2023 May 26, 2023 Read transcript
Q3 FY2023 Feb 2, 2023 Read transcript